Quantcast

Promega Protocols & Applications App Now Available for Android Devices

July 7, 2011

Promega announces its popular Protocols & Applications App is now available for Android devices.

Madison, WI (PRWEB) July 06, 2011

The Promega App, containing protocols, reference information and molecular biology calculators, is now available for Android. With this release, the popular Promega App is now available on both Apple and Android devices.

The App provides reference information and tools for life scientists. It combines quick calculators for use at the bench with video protocols and in-depth reference materials covering key topics in molecular and cell biology. The popular Protocols & Applications Guide section now includes 15 chapters of reference information and protocols for covering basic concepts like Buffers, PCR, Apoptosis, DNA Purification, and more. The protocols, calculators and videos featured in the App have long been popular features on the Promega web site and have been available as an iPhone App for the last two years.

With this release, the content of the Promega App continues to keep pace with the evolution of information delivery in today’s world. Promega will continue to explore dynamic delivery methods that strive to meet or exceed the expectations of the scientific community and offer rich and specific information whenever and wherever it is needed.

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit http://www.promega.com.

iPad is a trademark of Apple Inc., registered in the U.S. and other countries. iPhone is a trademark of Apple Inc.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/7/prweb8610276.htm


Source: prweb



comments powered by Disqus